Abstract
Hepatic encephalopathy (HE) is a diverse manifestation of acute and chronic liver failure, ranging from cognitive impairment, only detectable on psychometric evaluation through to confusion, coma and death from cerebral oedema. While there is widespread acceptance of its importance, there is little consensus on how best to diagnose and monitor HE. Clinical descriptions, psychometric testing, electroencephalography and magnetic resonance (MR) imaging (and lately, MR spectroscopy) have all been proposed. MR techniques, in contrast to other modalities, have the benefit of objectivity and of being able to interrogate the brain directly with respect to changes in brain size, function and the metabolic disturbances thought to underlie HE, particularly in the context of astrocyte swelling. Modern clinical MRI scanners with multinuclear MR spectroscopy capabilities and brain mapping software can demonstrate structural and functional cellular changes using volumetric MRI, magnetization transfer MRI, diffusion-weighting MRI, functional MRI with oxygenation measurements and in vivo and in vitro 1H and 31P MR spectroscopy. This review describes the relative merits of these techniques and provides guidance on the directions for future research and translation into clinical practice.
Similar content being viewed by others
Abbreviations
- ADC:
-
apparent diffusion coefficient
- ALF:
-
acute liver failure
- ATP:
-
adenosine triphosphate
- BOLD:
-
blood oxygenation level dependent
- CLF:
-
chronic liver failure
- DWI:
-
diffusion-weighted imaging
- FA:
-
fractional anisotropy
- fMRI:
-
functional magnetic resonance imaging
- HE:
-
hepatic encephalopathy
- MHE:
-
minimal hepatic encephalopathy
- MRI:
-
magnetic resonance imaging
- MRS:
-
magnetic resonance spectroscopy
- MTR:
-
magnetization transfer ratio
- NAA:
-
N-acetyl aspartate
- Pi:
-
inorganic phosphate
- PDE:
-
phosphodiesters
- PME:
-
phosphomonoesters
References
Babington JR, Stahl JH, Coy DL (2009) Reversible cytotoxic edema in a cirrhotic patient following TIPS. J Neuroimaging
Barba I, Chatauret N, Garcia-Dorado D, Cordoba J (2008) A 1H nuclear magnetic resonance-based metabonomic approach for grading hepatic encephalopathy and monitoring the effects of therapeutic hypothermia in rats. Liver Int 28:1141–1148
Barker PB, Golay X, Artemov D, Ouwerkerk R, Smith MA, Shaka AJ (2001) Broadband proton decoupling for in vivo brain spectroscopy in humans. Magn Reson Med 45:226–232
Berding G, Banati RB, Buchert R, Chierichetti F, Grover VP, Kato A, Keiding S, Taylor-Robinson SD (2009) Radiotracer imaging studies in hepatic encephalopathy: ISHEN practice guidelines. Liver Int 29:621–628
Binesh N, Huda A, Thomas MA, Wyckoff N, Bugbee M, Han S, Rasgon N, Davanzo P, Sayre J, Guze B, Martin P, Fawzy F (2006) Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study. J Appl Clin Med Phys 7:86–96
Bluml S, Zuckerman E, Tan J, Ross BD (1998) Proton-decoupled 31P magnetic resonance spectroscopy reveals osmotic and metabolic disturbances in human hepatic encephalopathy. J Neurochem 71:1564–1576
Bosman DK, Deutz NE, Maas MA, van Eijk HM, Smit JJ, de Haan JG, Chamuleau RA (1992) Amino acid release from cerebral cortex in experimental acute liver failure, studied by in vivo cerebral cortex microdialysis. J Neurochem 59:591–599
Butterworth RF (1997) Hepatic encephalopathy and brain edema in acute hepatic failure: does glutamate play a role? Hepatology 25:1032–1034
Butterworth RF, Giguere JF, Michaud J, Lavoie J, Layrargues GP (1987) Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 6:1–12
Butterworth RF, Spahr L, Fontaine S, Layrargues GP (1995) Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab Brain Dis 10:259–267
Chenevert TL, Brunberg JA, Pipe JG (1990) Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology 177:401–405
Cordoba J, Blei AT (1996) Brain edema and hepatic encephalopathy. Semin Liver Dis 16:271–280
Cordoba J, Alonso J, Rovira A, Jacas C, Sanpedro F, Castells L, Vargas V, Margarit C, Kulisewsky J, Esteban R, Guardia J (2001a) The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H- magnetic resonance abnormalities after liver transplantation. J Hepatol 35:598–604
Cordoba J, Olive G, Alonso J, Rovira A, Segarra A, Perez M, Jacas C, Vargas V (2001b) Improvement of magnetic resonance spectroscopic abnormalities but not pallidal hyperintensity followed amelioration of hepatic encephalopathy after occlusion of a large spleno-renal shunt. J Hepatol 34:176–178
Cox IJ (1996) Development and applications of in vivo clinical magnetic resonance spectroscopy. Prog Biophys Mol Biol 65:45–81
Das K, Singh P, Chawla Y, Duseja A, Dhiman RK, Suri S (2008) Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension. Dig Dis Sci 53:2793–2798
Dhiman RK, Chawla YK (2009) Minimal hepatic encephalopathy. Indian J Gastroenterol 28:5–16
Doran M, Hajnal JV, Van Bruggen N, King MD, Young IR, Bydder GM (1990) Normal and abnormal white matter tracts shown by MR imaging using directional diffusion weighted sequences. J Comput Assist Tomogr 14:865–873
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721
Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD (2002) Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 35:433–439
Fukuzawa T, Matsutani S, Maruyama H, Akiike T, Saisho H, Hattori T (2006) Magnetic resonance images of the globus pallidus in patients with idiopathic portal hypertension: a quantitative analysis of the relationship between signal intensity and the grade of portosystemic shunt. J Gastroenterol Hepatol 21:902–907
Grover VP, Dresner MA, Forton DM, Counsell S, Larkman DJ, Patel N, Thomas HC, Taylor-Robinson SD (2006) Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol 12:2969–2978
Hass HG, Nagele T, Seeger U, Hosl F, Gregor M, Kaiser S (2005) Detection of subclinical and overt hepatic encephalopathy and treatment control after L- ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H- MRS). Z Gastroenterol 43:373–378
Haussinger D (2006) Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 43:1187–1190
Haussinger D, Schliess F (2005) Astrocyte swelling and protein tyrosine nitration in hepatic encephalopathy. Neurochem Int 47:64–70
Haussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, Gerok W, Hennig J (1994) Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 107:1475–1480
Haussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S (2000) Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 32:1035–1038
Haussinger D, Schliess F, Kircheis G (2002) Pathogenesis of hepatic encephalopathy. J Gastroenterol Hepatol 17(Suppl 3):S256–259
Jenkinson M, Smith S (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5:143–156
Jones EA, Lavini C (2002) Is cerebral edema a component of the syndrome of hepatic encephalopathy? Hepatology 35:1270–1273
Kang N, Zhang J, Carlson ES, Gembris D (2005) White matter fiber tractography via anisotropic diffusion simulation in the human brain. IEEE Trans Med Imaging 24:1127–1137
Kreis R, Ross BD, Farrow NA, Ackerman Z (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182:19–27
Larsen FS (2000) Hepatic encephalopathy and brain edema. Ugeskr Laeger 162:2727–2730
Layrargues GP, Shapcott D, Spahr L, Butterworth RF (1995) Accumulation of manganese and copper in pallidum of cirrhotic patients: role in the pathogenesis of hepatic encephalopathy? Metab Brain Dis 10:353–356
Lemberg A, Fernandez MA (2009) Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress. Ann Hepatol 8:95–102
Lodi R, Tonon C, Stracciari A, Weiger M, Camaggi V, Iotti S, Donati G, Guarino M, Bolondi L, Barbiroli B (2004) Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. Neurology 62:762–766
Luyten PR, Bruntink G, Sloff FM, Vermeulen JW, van der Heijden JI, den Hollander JA, Heerschap A (1989) Broadband proton decoupling in human 31P NMR spectroscopy. NMR Biomed 1:177–183
Minguez B, Garcia-Pagan JC, Bosch J, Turnes J, Alonso J, Rovira A, Cordoba J (2006) Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 43:707–714
Mizuta Y, Ijyuin H, Ono N, Miyamoto Y, Oho K, Kumashiro R, Toyonaga A, Sata M, Nakashima O, Nagata E (2002) Disappearance of basal ganglia hyperintensity on T1-weighted MR images after obliterating portal systemic shunt in a patient with hepatic encephalopathy. Nippon Shokakibyo Gakkai Zasshi 99:1487–1492
Mullen KD (2007) Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Aliment Pharmacol Ther 25(Suppl 1):11–16
Naegele T, Grodd W, Viebahn R, Seeger U, Klose U, Seitz D, Kaiser S, Mader I, Mayer J, Lauchart W, Gregor M, Voigt K (2000) MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology 216:683–691
Nolte W, Wiltfang J, Schindler CG, Unterberg K, Finkenstaedt M, Niedmann PD, Hartmann H, Ramadori G (1998) Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. J Hepatol 29:443–449
Patel N, Forton DM, Coutts GA, Thomas HC, Taylor-Robinson SD (2000) Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: a phosphorus-31 MR spectroscopy study. Metab Brain Dis 15:223–240
Patel N, White S, Dhanjal NS, Oatridge A, Taylor-Robinson SD (2004) Changes in brain size in hepatic encephalopathy: a coregistered MRI study. Metab Brain Dis 19:431–445
Pujol A, Graus F, Peri J, Mercader JM, Rimola A (1991) Hyperintensity in the globus pallidus on T1-weighted and inversion-recovery MRI: a possible marker of advanced liver disease. Neurology 41:1526–1527
Rai V, Nath K, Saraswat VA, Purwar A, Rathore RK, Gupta RK (2008) Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging. J Magn Reson Imaging 28:334–341
Ross BD, Danielsen ER, Bluml S (1996) Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Dig Dis 14(Suppl 1):30–39
Rovira A, Grive E, Pedraza S, Alonso J (2001) Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. AJNR Am J Neuroradiol 22:1137–1142
Saraswat VA, Saksena S, Nath K, Mandal P, Singh J, Thomas MA, Rathore RS, Gupta RK (2008) Evaluation of mannitol effect in patients with acute hepatic failure and acute-on-chronic liver failure using conventional MRI, diffusion tensor imaging and in-vivo proton MR spectroscopy. World J Gastroenterol 14:4168–4178
Saxena V, Gupta A, Nagana Gowda GA, Saxena R, Yachha SK, Khetrapal CL (2006) 1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure. NMR Biomed 19:521–526
Schulz GJ, Coelho JC, Matias JE, Campos AC, Schulz DD, Bertoldi GA (2009) Cerebral magnetic resonance spectroscopy in patients with hepatic encephalopathy: analysis before and after liver transplantation. Rev Assoc Med Bras 55:35–39
Shah NJ, Neeb H, Kircheis G, Engels P, Haussinger D, Zilles K (2008) Quantitative cerebral water content mapping in hepatic encephalopathy. Neuroimage 41:706–717
Smith SM, De Stefano N, Jenkinson M, Matthews PM (2001) Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr 25:466–475
Sugimoto R, Iwasa M, Maeda M, Urawa N, Tanaka H, Fujita N, Kobayashi Y, Takeda K, Kaito M, Takei Y (2008) Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am J Gastroenterol 103:1413–1420
Taylor-Robinson SD, Sargentoni J, Mallalieu RJ, Bell JD, Bryant DJ, Coutts GA, Morgan MY (1994a) Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology 20:1173–1178
Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ (1994b) Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 9:347–359
Taylor-Robinson SD, Oatridge A, Hajnal JV, Burroughs AK, McIntyre N, deSouza NM (1995) MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis 10:175–188
Taylor-Robinson SD, Sargentoni J, Oatridge A, Bryant DJ, Hajnal JV, Marcus CD, Seery JP, Hodgson HJ, deSouza NM (1996) MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1- weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab Brain Dis 11:249–268
Taylor-Robinson SD, Buckley C, Changani KK, Hodgson HJ, Bell JD (1999) Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver 19:389–398
Torre Delgadillo A, Guerrero-Hernandez I, Uribe M (2006) Minimal hepatic encephalopathy: characteristics, diagnosis and clinical implications. Rev Gastroenterol Mex 71:63–70
Uchino A, Hasuo K, Matsumoto S, Masuda K (1994) Cerebral magnetic resonance imaging of liver cirrhosis patients. Clin Imaging 18:123–130
Vaquero J, Chung C, Blei AT (2003) Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy. Ann Hepatol 2:12–22
Wang YM (2004) The definition, nomenclature and diagnosis of hepatic encephalopathy. Zhonghua Gan Zang Bing Za Zhi 12:305–306
Weissenborn K, Ehrenheim C, Hori A, Kubicka S, Manns MP (1995) Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation. Metab Brain Dis 10:219–231
Williams HR, Cox IJ, Taylor-Robinson SD (2008) Metabonomics in hepatic encephalopathy: lucidity emerging from confusion. Liver Int 28:1050–1051
Zafiris O, Kircheis G, Rood HA, Boers F, Haussinger D, Zilles K (2004) Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study. Neuroimage 22:541–552
Zeneroli ML, Cioni G, Crisi G, Vezzelli C, Ventura E (1991) Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study. Magn Reson Imaging 9:295–302
Zhang LJ, Yang G, Yin J, Liu Y, Qi J (2007) Neural mechanism of cognitive control impairment in patients with hepatic cirrhosis: a functional magnetic resonance imaging study. Acta Radiol 48:577–587
Acknowledgements
The United Kingdom NIHR Biomedical Research Facility provided infrastructure support to both MJWM and SDT-R. The Wellcome Trust (London, UK) provided financial support to MJWM. We are grateful to Professors Howard Thomas and Claude Marcus, Drs Bob Grover, Jane Cox, Marzena Wylezinska-Arridge, David Larkman, Daniel M. Forton, Nayna Patel, Mary Crossey and Julie Fitzpatrick for useful discussions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McPhail, M.J.W., Taylor-Robinson, S.D. The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy. Metab Brain Dis 25, 65–72 (2010). https://doi.org/10.1007/s11011-010-9171-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-010-9171-4